Influence of birthweight and current body mass on cardiovascular risk factors in young adults;Wpływ urodzeniowej i aktualnej masy ciała na czynniki ryzyka wysta̧pienia chorób sercowo-naczyniowych u młodych osób dorosłych

Polskie Archiwum Medycyny Wewnetrznej

Volumn 117, Issue 3, 2007, Pages 13-19

  Szostak Wȩgierek, Dorota ^a   Szamotulska, Katarzyna ^b   Stolarska, Irena ^a  

^a Instytut Zywno ci i Zywienia   (Poland)

^b INSTITUTE OF MOTHER AND CHILD   (Poland)

Author keywords

Birthweight; Body mass index; Cardiovascular risk factors; Insulin resistance; Young adults

Indexed keywords

CHOLESTEROL; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; WAIST CIRCUMFERENCE;

EID: 34347248744     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Barker DJ. The developmental origins of insulin resistance. Horm Res. 2005; 64 (Suppl 3): 2S-7S.
2. Barker DJ. Developmental antecedents of cardiovascular disease: a historical perspective. J Am Soc Nephrol. 2005; 16: 2537-2544.
3. Barker DJ. The developmental origins of adult disease. J Am Coll Nutr. 2004; 23: 588S-595S.
4. Godfrey KM, Barker DJP. Fetal nutrition and adult disease. Am J Clin Nutr. 2000; 71 (Suppl): 1344S-1352S.
5. Eurodiet core report. Nutrition and diet for healthy lifestyles in Europe: science and policy implications. Public Health Nutr. 2001; 4: 265-273.
6. http://data.euro.who.int/hfadb/
7. Szamotulska K, Szostak-Wȩgierek D. Mała masa urodzeniowa a zespół X w wieku dorostym ("hipoteza Barkera"). Diabetologia Polska 1999; 6: 56-61.
8. Eriksson JG, Forsén T, Tuomilehto J, et al. Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals. Diabetologia 2002; 45: 342-348.
9. Bhargava SK, Sachdev HS, Fall CH, et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med. 2004; 350: 865-875.
10. Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G, et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab. 2004; 30: 253-258.
11. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil. 2003; 10 (Suppl 1): 1S-78S.
12. Program POL-Monica Bis Warszawa. Stan zdrowia ludności Warszawy w roku 2001. Czȩść I. Podstawowe wyniki badania przekrojowego. Instytut Kardiologii, Warszawa 2002.
13. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss. An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113: 898-918.
14. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive Summary. Circulation 2005; 112: e285-e290.